A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)
Evaluation of the Impact of a Topical Lotion, CG428, on Permanent Chemotherapy Induced Hair and Scalp Disorders in Cancer Survivors: An Open-label 6 Months Extension of VOLUME Study.
In the register
The register attaches this trial to CG 428 (Legacy Healthcare), currently at “Phase 2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Samsung Medical Center
- Participants (registry)
- 19
- Start
- January 2016
- Primary completion
- December 2016
- Study completion
- December 2017
- Last registry update
- September 2018
- Countries
- South Korea
Conditions studied: Alopecia, Chemotherapy Effects
Interventions: CG428
Other trials of CG 428
Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
- NCT02605629Completed
EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.